2022

• Decourt, M.; Balado, E.; Jiménez-Urbieta, H.; Francheteau, M.; Fernagut, P.-O.; Benoit-Marand, M. Assessment of Repetitive and Compulsive Behaviors Induced by Pramipexole in Rats: Effect of Alpha-Synuclein-Induced Nigrostriatal Degeneration. Biomedicines 2022, 10, 542. https://doi.org/10.3390/biomedicines10030542
• Thabault, M.; Turpin, V.; Maisterrena, A.; Jaber, M.; Egloff, M.; Galvan, L. Cerebellar and Striatal Implications in Autism Spectrum Disorders: From Clinical Observations to Animal Models. Int. J. Mol. Sci. 2022, 23, 2294. https://doi.org/10.3390/ijms23042294

2021

• Decourt, M., Jiménez-Urbieta, H., Benoit-Marand, M., Fernagut, P.-O., Neuropsychiatric and Cognitive Deficits in Parkinson’s Disease and Their Modeling in Rodents. Biomedicines 2021, 9, 684. https://doi.org/10.3390/biomedicines9060684
• Westphal WP, Rault C, Robert R, Ragot S, Neau JP, Fernagut PO, Drouot X. Sleep deprivation reduces vagal tone during an inspiratory endurance task in humans. Sleep. 2021 Oct 11;44(10):zsab105. doi: 10.1093/sleep/zsab105. PMID: 33895822.

2020

• Fries N, Le Garrec S, Egloff M, Sault C, DreuxS, Mangione R, Salomon LJ, Ville Y. Non-invasive prenatal testing: what are we missing? Ultrasound Obstet Gynecol
• Rault C, Sangare A, Diaz V, Ragot S, Frat JP, Raux M, Similowski T, Robert R, Thille AW, Drouot X. Impact of Sleep Deprivation on Respiratory Motor Output and Endurance. A Physiological Study. Am J Respir Crit Care Med2020; 201: 976-83
• Lopez-Cuina M, Guerin PA, Canron MH, Delamarre A, Dehay B, BezardE, Meissner WG, Fernagut PO. Nilotinib Fails to Prevent Synucleinopathy and Cell Loss in a Mouse Model of Multiple System Atrophy. Mov Disord2020; 35: 1163-72.

2019

• Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies.Arotcarena ML, Bourdenx M, Dutheil N, Thiolat ML, Doudnikoff E, Dovero S, Ballabio A, Fernagut PO, Meissner WG, Bezard E, Dehay B.JCI Insight. 2019 Aug 22;4(16). pii: 129719. doi: 10.1172/jci.insight.129719.IF: 6.01
• Dopamine and eating behavior disorders in Parkinson’s disease: A complex recipe. Fernagut PO.Mov Disord. 2019 Jun;34(6):767-768. doi: 10.1002/mds.27703. IF: 8.3
• l-Dopa-free learned dyskinetic behavior in a Parkinson’s primate model. Li Q, Fernagut PO, Bezard E.Mov Disord. 2019 Aug;34(8):1237. doi: 10.1002/mds.27715. Epub 2019 May 13. No abstract available.IF: 8.3
• Sex-dependent behavioral deficits and neuropathology in a maternal immune activation model of autism.Haida O, Al Sagheer T, Balbous A, Francheteau M, Matas E, Soria F, Fernagut PO, Jaber M. Transl Psychiatry. 2019 Mar 28;9(1):124. doi: 10.1038/s41398-019-0457-y.
• Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson’s disease. Jiménez-Urbieta H, Gago B, Quiroga-Varela A, Rodríguez-Chinchilla T, Merino-Galán L, Oregi A, Belloso-Iguerategui A, Delgado-Alvarado M, Navalpotro-Gómez I, Marin C, Fernagut PO, Rodríguez-Oroz MC. Neurobiol Aging. 2019 Mar;75:126-135. doi: 10.1016/j.neurobiolaging.2018.11.021. Epub 2018 Nov 24. IF: 4.39
• Sleep and Pathological Wakefulness at the Time of Liberation from Mechanical Ventilation (SLEEWE). A Prospective Multicenter Physiological Study. Dres M, Younes M, Rittayamai N, Kendzerska T, Telias I, Grieco DL, Pham T, Junhasavasdikul D, Chau E, Mehta S, Wilcox ME, Leung R, Drouot X, Brochard L. Am J Respir Crit Care Med. 2019 May 1;199(9):1106-1115. doi: 10.1164/rccm.201811-2119OC.IF: 16.4
• Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington’s Disease Mice. Holley SM, Galvan L, Kamdjou T, Dong A, Levine MS, Cepeda C. Front Synaptic Neurosci. 2019 May 14;11:14. doi: 10.3389/fnsyn.2019.00014. eCollection 2019. IF: 2.1
• Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington’s disease. Holley SM, Galvan L, Kamdjou T, Cepeda C, Levine MS. Eur J Neurosci. 2019 Jan;49(1):79-93. doi: 10.1111/ejn.14283. Epub 2018 Dec 10. IF: 2.78
• Sex-dependent behavioral deficits and neuropathology in a maternal immune activation model of autism. Haida O, Al Sagheer T, Balbous A, Francheteau M, Matas E, Soria F, Fernagut PO, Jaber M. Transl Psychiatry. 2019 Mar 28;9(1):124. doi: 10.1038/s41398-019-0457-y. IF: 5.1
• Dopamine and addiction: what have we learned from 40 years of research. Solinas M, Belujon P, Fernagut PO, Jaber M, Thiriet N. J Neural Transm (Vienna). 2019 Apr;126(4):481-516. doi: 10.1007/s00702-018-1957-2. Epub 2018 Dec 19. Review. IF: 2.9
• TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Laferrière F, Maniecka Z, Pérez-Berlanga M, Hruska-Plochan M, Gilhespy L, Hock EM, Wagner U, Afroz T, Boersema PJ, Barmettler G, Foti SC, Asi YT, Isaacs AM, Al-Amoudi A, Lewis A, Stahlberg H, Ravits J, De Giorgi F, Ichas F, Bezard E, Picotti P, Lashley T, Polymenidou M. Nat Neurosci. 2019 Jan;22(1):65-77. doi: 10.1038/s41593-018-0294-y. Epub 2018 Dec 17. IF: 21.2

2018

• Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy. Lopez-Cuina M, Fernagut PO, Canron MH, Vital A, Lannes B, De Paula AM, Streichenberger N, Guehl D, Damier P, Eusebio A, Houeto JL, Tison F, Tranchant C, Viallet F, Witjas T, Thobois S, Meissner WG. Neurobiol Dis. 2018 Oct;118:155-160. doi: 10.1016/j.nbd.2018.07.016. Epub 2018 Jul 17. IF: 5.16
• Motor Impairments Correlate with Social Deficits and Restricted Neuronal Loss in an Environmental Model of Autism. Al Sagheer T, Haida O, Balbous A, Francheteau M, Matas E, Fernagut PO, Jaber M. Int J Neuropsychopharmacol. 2018 Sep 1;21(9):871-882. doi: 10.1093/ijnp/pyy043.
• CREB controls cortical circuit plasticity and functional recovery after stroke. Caracciolo L, Marosi M, Mazzitelli J, Latifi S, Sano Y, Galvan L, Kawaguchi R, Holley S, Levine MS, Coppola G, Portera-Cailliau C, Silva AJ, Carmichael ST. Nat Commun. 2018 Jun 8;9(1):2250. doi: 10.1038/s41467-018-04445-9. IF: 11.87
• The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin. Galvan L, Francelle L, Gaillard MC, de Longprez L, Carrillo-de Sauvage MA, Liot G, Cambon K, Stimmer L, Luccantoni S, Flament J, Valette J, de Chaldée M, Auregan G, Guillermier M, Joséphine C, Petit F, Jan C, Jarrige M, Dufour N, Bonvento G, Humbert S, Saudou F, Hantraye P, Merienne K, Bemelmans AP, Perrier AL, Déglon N, Brouillet E. Brain. 2018 May 1;141(5):1434-1454. doi: 10.1093/brain/awy057.
• Motor Impairments Correlate with Social Deficits and Restricted Neuronal Loss in an Environmental Model of Autism. Al Sagheer T, Haida O, Balbous A, Francheteau M, Matas E, Fernagut PO, Jaber M. Int J Neuropsychopharmacol. 2018 Sep 1;21(9):871-882. doi: 10.1093/ijnp/pyy043. IF: 4.2
• 2008-2018: Ten years of gradual changes in the sedation guidelines for critically ill patients.Chanques G, Drouot X, Payen JF. Anaesth Crit Care Pain Med. 2018 Dec;37(6):509-511. doi: 10.1016/j.accpm.2018.10.014. Epub 2018 Oct 26. No abstract available. IF: 2.7
• Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, Watson PL, Weinhouse GL, Nunnally ME, Rochwerg B, Balas MC, van den Boogaard M, Bosma KJ, Brummel NE, Chanques G, Denehy L, Drouot X, Fraser GL, Harris JE, Joffe AM, Kho ME, Kress JP, Lanphere JA, McKinley S, Neufeld KJ, Pisani MA, Payen JF, Pun BT, Puntillo KA, Riker RR, Robinson BRH, Shehabi Y, Szumita PM, Winkelman C, Centofanti JE, Price C, Nikayin S, Misak CJ, Flood PD, Kiedrowski K, Alhazzani W. Crit Care Med. 2018 Sep;46(9):e825-e873. doi: 10.1097/CCM.0000000000003299. IF: 6.9
• Executive Summary: Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, Watson PL, Weinhouse GL, Nunnally ME, Rochwerg B, Balas MC, van den Boogaard M, Bosma KJ, Brummel NE, Chanques G, Denehy L, Drouot X, Fraser GL, Harris JE, Joffe AM, Kho ME, Kress JP, Lanphere JA, McKinley S, Neufeld KJ, Pisani MA, Payen JF, Pun BT, Puntillo KA, Riker RR, Robinson BRH, Shehabi Y, Szumita PM, Winkelman C, Centofanti JE, Price C, Nikayin S, Misak CJ, Flood PD, Kiedrowski K, Alhazzani W.Crit Care Med. 2018 Sep;46(9):1532-1548. doi: 10.1097/CCM.0000000000003259. No abstract available. IF: 6.9
• Impact of sleep alterations on weaning duration of mechanically ventilated patients: how much is bad? Thille AW, Coudroy R, Reynaud F, Marie D, Barrau S, Rousseau L, Rault C, Diaz V, Meurice JC, Frat JP, Robert R, Drouot X. Eur Respir J. 2018 Jul 4;52(1). pii: 1800979. doi: 10.1183/13993003.00979-2018. Print 2018 Jul. IF: 11.8
• Are Sleep Alterations the Cause of ICU Delirium? Thille AW, Reynaud F, Marie D, Barrau S, Rousseau L, Rault C, Drouot X. Am J Respir Crit Care Med. 2018 Sep 1;198(5):692-693. doi: 10.1164/rccm.201804-0609LE. IF: 16.4
• Impact of sleep alterations on weaning duration in mechanically ventilated patients: a prospective study. Thille AW, Reynaud F, Marie D, Barrau S, Rousseau L, Rault C, Diaz V, Meurice JC, Coudroy R, Frat JP, Robert R, Drouot X. Eur Respir J. 2018 Apr 19;51(4). pii: 1702465. doi: 10.1183/13993003.02465-2017. Print 2018 Apr. IF: 11.8
• Optogenetic Tractography for anatomo-functional characterization of cortico-subcortical neural circuits in non-human primates. Senova S, Poupon C, Dauguet J, Stewart HJ, Dugué GP, Jan C, Hosomi K, Ralph GS, Barnes L, Drouot X, Pouzat C, Mangin JF, Pain F, Doignon I, Aron-Badin R, Brouillet E, Boyden ES, Mitrophanous KA, Hantraye P, Palfi S. Sci Rep. 2018 Feb 20;8(1):3362. doi: 10.1038/s41598-018-21486-8.
• High prevalence of sleep apnea syndrome in patients admitted to ICU for acute hypercapnic respiratory failure: a preliminary study. Thille AW, Córdoba-Izquierdo A, Maitre B, Boyer L, Brochard L, Drouot X. Intensive Care Med. 2018 Feb;44(2):267-269. doi: 10.1007/s00134-017-4998-3. Epub 2017 Nov 20. IF: 18.9

2017

• A Delay between Motor Cortex Lesions and Neuronal Transplantation Enhances Graft Integration and Improves Repair and Recovery. Péron S, Droguerre M, Debarbieux F, Ballout N, Benoit-Marand M, Francheteau M, Brot S, Rougon G, Jaber M, Gaillard A. J Neurosci. 2017 Feb 15;37(7):1820-1834. doi: 10.1523/JNEUROSCI.2936-16.2017. Epub 2017 Jan 13. IF : 6.07
• Building Bridges through Science. Lissek T, Adams M, Adelman J, Ahissar E, Akaaboune M, Akil H, al’Absi M, Arain F, Arango-Lasprilla JC, Atasoy D, Avila J, Badawi A, Bading H, Baig AM, Baleriola J, Belmonte C, Bertocchi I, Betz H, Blakemore C, Blanke O, Boehm-Sturm P, Bonhoeffer T, Bonifazi P, Brose N, Campolongo P, Celikel T, Chang CC, Chang TY, Citri A, Cline HT, Cortes JM, Cullen K, Dean K, Delgado-Garcia JM, Desroches M, Disterhoft JF, Dowling JE, Draguhn A, El-Khamisy SF, El Manira A, Enam SA, Encinas JM, Erramuzpe A, Esteban JA, Fariñas I, Fischer E, Fukunaga I, Gabilondo I, Ganten D, Gidon A, Gomez-Esteban JC, Greengard P, Grinevich V, Gruart A, Guillemin R, Hariri AR, Hassan B, Häusser M, Hayashi Y, Hussain NK, Jabbar AA, Jaber M, Jahn R, Janahi EM, Kabbaj M, Kettenmann H, Kindt M, Knafo S, Köhr G, Komai S, Krugers H, Kuhn B, Ghazal NL, Larkum ME, London M, Lutz B, Matute C, Martinez-Millan L, Maroun M, McGaugh J, Moustafa AA, Nasim A, Nave KA, Neher E, Nikolich K, Outeiro T, Palmer LM, Penagarikano O, Perez-Otano I, Pfaff DW, Poucet B, Rahman AU, Ramos-Cabrer P, Rashidy-Pour A, Roberts RJ, Rodrigues S, Sanes JR, Schaefer AT, Segal M, Segev I, Shafqat S, Siddiqui NA, Soreq H, Soriano-García E, Spanagel R, Sprengel R, Stuart G, Südhof TC, Tønnesen J, Treviño M, Uthman BM, Venter JC, Verkhratsky A, Weiss C, Wiesel TN, Yaksi E, Yizhar O, Young LJ, Young P, Zawia NH, Zugaza JL, Hasan MT. 2017 Nov 15;96(4):730-735. doi: 10.1016/j.neuron.2017.09.028. IF: 14.4
• Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.Bassil F, Guerin PA, Dutheil N, Li Q, Klugmann M, Meissner WG, Bezard E, Fernagut PO.Mov Disord. 2017 Aug;32(8):1230-1239. doi: 10.1002/mds.27041. Epub 2017 May 29.
• Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia. Bastide MF, Glangetas C, Doudnikoff E, Li Q, Bourdenx M, Fernagut PO, Dumont ÉC, Georges F, Bézard E. Sci Rep. 2017 May 24;7(1):2348. doi: 10.1038/s41598-017-02572-9. IF : 4.01
• Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration. Soria FN, Engeln M, Martinez-Vicente M, Glangetas C, López-González MJ, Dovero S, Dehay B, Normand E, Vila M, Favereaux A, Georges F, Lo Bianco C, Bezard E, Fernagut PO. Hum Mol Genet. 2017 Jul 15;26(14):2603-2615. doi: 10.1093/hmg/ddx120. IF: 4.54
• Multiple System Atrophy – State of the Art. Laurens B, Vergnet S, Lopez MC, Foubert-Samier A, Tison F, Fernagut PO, Meissner WG. Curr Neurol Neurosci Rep. 2017 May;17(5):41. doi: 10.1007/s11910-017-0751-0. Review. IF: 3.4
• Insulin resistance and exendin-4 treatment for multiple system atrophy. Bassil F, Canron MH, Vital A, Bezard E, Li Y, Greig NH, Gulyani S, Kapogiannis D, Fernagut PO, Meissner WG. Brain. 2017 May 1;140(5):1420-1436. doi: 10.1093/brain/awx044.
• French consensus. Management of patients with hypersomnia: Which strategy? Lopez R, Arnulf I, Drouot X, Lecendreux M, Dauvilliers Y. Rev Neurol (Paris). 2017 Jan – Feb;173(1-2):8-18. doi: 10.1016/j.neurol.2016.09.018. Epub 2016 Nov 16. Review. IF: 2.1
• Comorbidity between central disorders of hypersomnolence and immune-based disorders. Barateau L, Lopez R, Arnulf I, Lecendreux M, Franco P, Drouot X, Leu-Semenescu S, Jaussent I, Dauvilliers Y. Neurology. 2017 Jan 3;88(1):93-100. doi: 10.1212/WNL.0000000000003432. Epub 2016 Nov 18. IF: 8.68
• In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains. Cavaliere F, Cerf L, Dehay B, Ramos-Gonzalez P, De Giorgi F, Bourdenx M, Bessede A, Obeso JA, Matute C, Ichas F, Bezard E. Neurobiol Dis. 2017 Jul;103:101-112. doi: 10.1016/j.nbd.2017.04.011. Epub 2017 Apr 11.
• French consensus. Management of patients with hypersomnia: Which strategy?Lopez R, Arnulf I, Drouot X, Lecendreux M, Dauvilliers Y. Rev Neurol (Paris). 2017 Jan – Feb;173(1-2):8-18. doi: 10.1016/j.neurol.2016.09.018. Epub 2016 Nov 16. Review.IF: 2.1
• Comorbidity between central disorders of hypersomnolence and immune-based disorders.Barateau L, Lopez R, Arnulf I, Lecendreux M, Franco P, Drouot X, Leu-Semenescu S, Jaussent I, Dauvilliers Y. Neurology. 2017 Jan 3;88(1):93-100. doi: 10.1212/WNL.0000000000003432. Epub 2016 Nov 18. IF: 8.68

2016

• Chauvet C, Nicolas C, Lafay-chebassier C, Jaber M, Thiriet N, Solinas M « Statins reduce the risks of relapse to addiction in rats » Neuropsychopharm. 2016 May ;41(6) :1588-97.

2015

• Bassil F, Monvoisin A, Canron MH, Vital A, Meissner WG, Tison F, Fernagut PO: Region-Specific Alterations of Matrix Metalloproteinase Activity in Multiple System Atrophy. Mov Disord 2015; 30:1802-12,
• Bourdenx M, Dovero S, Engeln M, Bido S, Bastide MF, Dutheil N, Vollenweider I, Baud L, Piron C, Grouthier V, Boraud T, Porras G, Li Q, Baekelandt V, Scheller D, Michel A, Fernagut PO, Georges F, Courtine G, Bezard E, Dehay B: Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by alpha-synuclein overexpression. Acta Neuropathol Commun 2015; 3: 46
• Engeln M, De Deurwaerdere P, Li Q, Bezard E, Fernagut PO: Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and Dyskinesia. Cereb Cortex 2015; 25: 2783-92
• Arcuri L, Viaro R, Bido S, Longo F, Calcagno M, Fernagut PO, Zaveri NT, Calo G, Bezard E, Morari M: Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson’s disease. Neurobiol Dis 2016; 89: 55-64
• Bastide MF, de la Crompe B, Doudnikoff E, Fernagut PO, Gross CE, Mallet N, Boraud T, Bezard E:Inhibiting Lateral Habenula Improves L-DOPA-Induced Dyskinesia. Biol Psychiatry 2016; 79: 345-53
• Engeln M, Ansquer S, Dugast E, Bezard E, Belin D, Fernagut PO. Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy. Neuropharmacology 2016; 109: 69-77
• Engeln M, Bastide MF, Toulme E, Dehay B, Bourdenx M, Doudnikoff E, Li Q, Gross CE, Boue-Grabot E, Pisani A, Bezard E, Fernagut PO. Selective Inactivation of Striatal FosB/DeltaFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia. Biol Psychiatry 2016; 79: 354-61
• Rey C, Faustin B, Mahouche I, Ruggieri R, Brulard C, Ichas F, Soubeyran I, Lartigue L, De Giorgi F. « The
  MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer. » Oncogene. 2016 Jun 16;35(24):3190-200.
• Bassil F, Fernagut PO, Bezard E, Pruvost A, Leste-Lasserre T, Hoang Q, Ringe D, Petsko GA, Meissner WG.
  « Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy. » Proceedings of National Academy of Sciences USA 2016 (in
  press)

2014

• Vitrac C, Péron S, Frappé I, Fernagut P-O, Jaber M, Gaillard A, Benoit-Marand M. « Dopamine control of pyramidal neuron activity in the primary motor cortex via D2 receptors. » Front Neural Circuits 2014 Feb 28;8:13.
• Bastide MF, Dovero S, Charron G, Porras G, Gross CE, Fernagut PO, Bezard E: Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia. Neurobiol Dis 2014; 62: 179-92
• Fernagut PO, Meissner WG, Biran M, Fantin M, Bassil F, Franconi JM, Tison F: Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy. Synapse 2014; 68: 98-106
• Flabeau O, Meissner WG, Ozier A, Berger P, Tison F, Fernagut PO: Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy. Mov Disord 2014; 29: 388-95
• Recasens A, Dehay B, Bove J, Carballo-Carbajal I, Dovero S, Perez-Villalba A, Fernagut PO, Blesa J, Parent A, Perier C, Farinas I, Obeso JA, Bezard E, Vila M: Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol 2014; 75:351-62
• Houédé N, Pulido M, Mourey L, Joly F, Ferrero JM, Bellera C, Priou F, Lalet C, Laroche-Clary A, Raffin MC, Ichas F, Puech A, Piazza PV. « A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer. » Oncologist. 2014 Dec;19(12):1227-8.

2013

• Saha B, Peron S, Murray K, Jaber M, Gaillard A. Cortical lesion stimulates adult subventricular zone neural progenitor cell proliferation and migration to the site of injury. Stem Cell Res. 2013 Jun 24;11(3):965-977
• Engeln M, Ahmed SH, Vouillac C, Tison F, Bezard E, Fernagut PO: Reinforcing properties of Pramipexole
  in normal and parkinsonian rats. Neurobiol Dis 2013; 49: 79-86 18. Engeln M, Fasano S, Ahmed SH, Cador M, Baekelandt V, Bezard E, Fernagut PO: Levodopa gains psychostimulant-like properties after nigral dopaminergic loss. Ann Neurol 2013; 74: 140-4
• Winckler P, Lartigue L, Giannone G, De Giorgi F, Ichas F, Sibarita JB, Lounis B, Cognet L. « Identification
  and super-resolution imaging of ligand-activated receptor dimers in live cells. » Sci Rep. 2013;3:2387.
• Rey C, Soubeyran I, Mahouche I, Pedeboscq S, Bessede A, Ichas F, De Giorgi F, Lartigue L. « HIPK1 drives
  p53 activation to limit colorectal cancer cell growth. » Cell Cycle. 2013 Jun 15;12(12):1879-91

2012

• Nader J, El Rawas R, Chauvet C, Jaber M, Thiriet N, Solinas M. Loss of environmental enrichment increases vulnerability to cocaine addiction. Neuropsychopharmacology. 2012; 37(7): 1579-87.
• Decressac M, Pain S, Chabeauti P-Y, Frangeul L, Thiriet N, Herzog H, Vergote J, Chalon S, Jaber M, Gaillard A. Neuroprotection by neuropeptide Y in cell and animal models of Parkinson’s disease. Neurobiol Aging. 2012; 33(9): 2125–37.
• Chauvet C, Goldberg S R, Jaber M, Solinas M. Effects of environmental enrichment on the incubation of cocaine craving. Neuropharmacology. 2012; 63(4): 635-41.
• Fernagut PO, Vital A, Canron MH, Tison F, Meissner WG: Ambiguous mechanisms of dysphagia in
  multiple system atrophy. Brain 2012; 135: e205; author reply e206
• Pédeboscq S, Gravier D, Casadebaig F, Hou G, Gissot A, Rey C, Ichas F, De Giorgi F, Lartigue L, Pometan JP. « Synthesis and evaluation of apoptosis induction of thienopyrimidine compounds on KRAS and BRAF mutated colorectal cancer cell lines. » Bioorg Med Chem. 2012 Nov 15;20(22):6724-31.
• Pédeboscq S, Rey C, Petit M, Harpey C, De Giorgi F, Ichas F, Lartigue L. « Non-antioxidant properties of α-tocopherol reduce the anticancer activity of several protein kinase inhibitors in vitro. » PLoS One. 2012;7(5):e36811.
• Auzanneau C, Montaudon D, Jacquet R, Puyo S, Pouységu L, Deffieux D, Elkaoukabi-Chaibi A, De Giorgi F, Ichas F, Quideau S, Pourquier P. « The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II. » Mol Pharmacol. 2012 Jul;82(1):134-41.

2011

• Decressac M, Pain S, Chabeauti PY, Frangeul L, Thiriet N, Herzog H, Vergote J, Chalon S, Jaber M, Gaillard A Neuroprotection by neuropeptide Y in cell and animal models of Parkinson’s disease. Neurobiol Aging. 2012 Sep;33(9):2125-37.
• Chauvet C, Lardeux V, Jaber M, Solinas M. Brain regions associated with the reversal of cocaine conditioned place preference by environmental enrichment. Neuroscience. 2011 Jun 16;184:88-96.
• El Rawas R, Thiriet N, Nader J, Lardeux V, Jaber M, Solinas M. Early exposure to environmental enrichment alters the expression of genes of the endocannabinoid system. Brain Res. 2011 May 16;1390:80-9.
• Thiriet N, Agasse F, Nicoleau C, Guégan C, Vallette F, Cadet JL, Jaber M, Malva JO, Coronas V. NPY promotes chemokinesis and neurogenesis in the rat subventricular zone. J Neurochem. 2011 Mar;116(6):1018-27.
• Thiriet N, Gennequin B, Lardeux V, Chauvet C, Decressac M, Janet T, Jaber M, Solinas M. Environmental enrichment does not reduce the rewarding and neurotoxic effects of methamphetamine. Neurotox Res. 2011 Jan;19(1):172-82.
• Decressac M, Wright B, David B, Tyers P, Jaber M, Barker RA, Gaillard A. Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis. Hippocampus. 2011 Mar;21(3):233-8.
• Fernagut PO. Links between glucocerebrosidase and alpha-synuclein revealed. Mov Disord. 2011 Oct;26(12):2177.
• Fantin M, Morari M, Tison F, Fernagut PO. NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acid. Neurol Res. 2011 May;33(4):444-7.
• Leger F, Fernagut PO, Canron MH, Léoni S, Vital C, Tison F, Bezard E, Vital A. Protein aggregation in the aging retina. J Neuropathol Exp Neurol. 2011 Jan;70(1):63-8.
• Soubeyran I, Mahouche I, Grigoletto A, Leste-Lasserre T, Drutel G, Rey C, Pedeboscq S, Blanchard F, Brouste V, Sabourin JC, Bécouarn Y, Reiffers J, Ichas F, De Giorgi F. Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function. Am J Pathol. 2011 May;178(5):1986-98.
• Annibale B, Maconi G, Lahner E, De Giorgi F, Cuomo R. Efficacy of Lactobacillus paracasei sub. paracasei F19 on abdominal symptoms in patients with symptomatic uncomplicated diverticular disease: a pilot study. Minerva Gastroenterol Dietol. 2011 Mar;57(1):13-22.
• Compare D, Pica L, Rocco A, De Giorgi F, Cuomo R, Sarnelli G, Romano M, Nardone G. Effects of long-term PPI treatment on producing bowel symptoms and SIBO. Eur J Clin Invest. 2011 Apr;41(4):380-6.